Related references
Note: Only part of the references are listed.The Epigenetic Regulator I-BET151 Induces BIM-Dependent Apoptosis and Cell Cycle Arrest of Human Melanoma Cells
Stuart J. Gallagher et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Brd4 maintains constitutively active NF-κB in cancer cells by binding to acetylated RelA
Z. Zou et al.
ONCOGENE (2014)
BRD4 Sustains Melanoma Proliferation and Represents a New Target for Epigenetic Therapy
Miguel F. Segura et al.
CANCER RESEARCH (2013)
The Activation of MAPK in Melanoma Cells Resistant to BRAF Inhibition Promotes PD-L1 Expression That Is Reversible by MEK and PI3K Inhibition
Xiaofeng Jiang et al.
CLINICAL CANCER RESEARCH (2013)
BET Protein Function Is Required for Inflammation: Brd2 Genetic Disruption and BET Inhibitor JQ1 Impair Mouse Macrophage Inflammatory Responses
Anna C. Belkina et al.
JOURNAL OF IMMUNOLOGY (2013)
The IKK Inhibitor Bay 11-7082 Induces Cell Death Independent from Inhibition of Activation of NFκB Transcription Factors
Hilka Rauert-Wunderlich et al.
PLOS ONE (2013)
Inhibiting EGF Receptor or SRC Family Kinase Signaling Overcomes BRAF Inhibitor Resistance in Melanoma
Maria R. Girotti et al.
CANCER DISCOVERY (2013)
Relief of Profound Feedback Inhibition of Mitogenic Signaling by RAF Inhibitors Attenuates Their Activity in BRAFV600E Melanomas
Piro Lito et al.
CANCER CELL (2012)
Ikk4a/Arf Inactivation with Activation of the NF-κB/IL-6 Pathway Is Sufficient to Drive the Development and Growth of Angiosarcoma
Jinming Yang et al.
CANCER RESEARCH (2012)
NF-κB, the first quarter-century: remarkable progress and outstanding questions
Matthew S. Hayden et al.
GENES & DEVELOPMENT (2012)
NF-κB and chromatin: ten years on the path from basic mechanisms to candidate drugs
Gioacchino Natoli
IMMUNOLOGICAL REVIEWS (2012)
Dimer-specific regulatory mechanisms within the NF-κB family of transcription factors
Stephen T. Smale
IMMUNOLOGICAL REVIEWS (2012)
Down-regulation of NF-κB Transcriptional Activity in HIV-associated Kidney Disease by BRD4 Inhibition
Guangtao Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
NF-κB as potential target in the treatment of melanoma
Gabriele Madonna et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation
Jennifer Landsberg et al.
NATURE (2012)
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
Ravid Straussman et al.
NATURE (2012)
Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors
Timothy R. Wilson et al.
NATURE (2012)
Evidence for upregulation of Bim and the splicing factor SRp55 in melanoma cells from patients treated with selective BRAF inhibitors
Fritz Lai et al.
MELANOMA RESEARCH (2012)
NF-κB inducing kinase (NIK) modulates melanoma tumorigenesis by regulating expression of pro-survival factors through the β-catenin pathway
Y. M. Thu et al.
ONCOGENE (2012)
BRD4 is an atypical kinase that phosphorylates Serine2 of the RNA Polymerase II carboxy-terminal domain
Ballachanda N. Devaiah et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The Unholy Trinity: Inflammation, Cytokines, and STAT3 Shape The Cancer Microenvironment
Ning Li et al.
CANCER CELL (2011)
被撤回的出版物: Molecular Mechanism of MART-1+/A*0201+ Human Melanoma Resistance to Specific CTL-Killing Despite Functional Tumor-CTL Interaction (Retracted article. See vol. 77, pg. 3718, 2017)
Ali R. Jazirehi et al.
CANCER RESEARCH (2011)
Role of nuclear factor-κB-mediated inflammatory pathways in cancer-related symptoms and their regulation by nutritional agents
Subash C. Gupta et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2011)
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
Mark A. Dawson et al.
NATURE (2011)
NF-κB addiction and its role in cancer: 'one size does not fit all'
M. M. Chaturvedi et al.
ONCOGENE (2011)
Inhibiting NF-kappa B activation by small molecules as a therapeutic strategy
Subash C. Gupta et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2010)
Requirement of the NF-κB Subunit p65/RelA for K-Ras-Induced Lung Tumorigenesis
Daniela S. Basseres et al.
CANCER RESEARCH (2010)
Amino terminal hydrophobic import signals target the p14ARF tumor suppressor to the mitochondria
Mal Irvine et al.
CELL CYCLE (2010)
CXCL8 and its cognate receptors in melanoma progression and metastasis
Seema Singh et al.
FUTURE ONCOLOGY (2010)
Suppression of inflammation by a synthetic histone mimic
Edwige Nicodeme et al.
NATURE (2010)
Selective inhibition of BET bromodomains
Panagis Filippakopoulos et al.
NATURE (2010)
IKKγ protein is a target of BAG3 regulatory activity in human tumor growth
Massimo Ammirante et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
QuickGO: a web-based tool for Gene Ontology searching
David Binns et al.
BIOINFORMATICS (2009)
IKK/NF-κB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis
Julia Bollrath et al.
EMBO REPORTS (2009)
Brd4 Coactivates Transcriptional Activation of NF-κB via Specific Binding to Acetylated RelA
Bo Huang et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
The good and the bad of chemokines/chemokine receptors in melanoma
Ann Richmond et al.
PIGMENT CELL & MELANOMA RESEARCH (2009)
The lymphotoxin-β receptor is an upstream activator of NF-κB-mediated transcription in melanoma cells
Punita Dhawan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Oncogenic BRAF regulates β-Trcp expression and NF-κB activity in human melanoma cells
J. Liu et al.
ONCOGENE (2007)
Identification of transcription complexes that contain the double bromodomain protein Brd2 and chromatin remodeling machines
GV Denis et al.
JOURNAL OF PROTEOME RESEARCH (2006)
BMS-345541 targets inhibitor of κB kinase and induces apoptosis in melanoma:: Involvement of nuclear factor κB and mitochondria pathways
JM Yang et al.
CLINICAL CANCER RESEARCH (2006)
NFκB:: Linking inflammation and immunity to cancer development and progression
M Karin et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Impaired inhibition of NF-κB activity by melanoma-associated p16INK4a mutations
TM Becker et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
NF-κB, chemokine gene transcription and tumour growth
A Richmond
NATURE REVIEWS IMMUNOLOGY (2002)
The role of NF-κB in TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of melanoma cells
AV Franco et al.
JOURNAL OF IMMUNOLOGY (2001)
Share Paper
